CD4 and neoplasm: nTregs are mainly CD4+ Tregs that mature after IL-2 and IL-15 stimulation in the thymus and maintain immune tolerance in peripheral areas of inflammation or tumor tissues, and account for approximately 1–3% of total CD4+ T lymphocytes [29,30].